Related Experiment Videos
Combination chemotherapy in radically operated advanced ovarian cancer
E Petru1, H Pickel, M Lahousen
1Department of Obstetrics and Gynecology, University of Graz, Austria.
Cancer Treatment Reviews
|September 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Annals of oncology : official journal of the European Society for Medical Oncology·2016
[Peripartum aortic dissection].
Der Anaesthesist·2013
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
British journal of cancer·2011
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.
Cancer treatment reviews·2026
Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.
Cancer treatment reviews·2026
Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.
Cancer treatment reviews·2026
Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.
Naunyn-Schmiedeberg's archives of pharmacology·2026